Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04416412 · ClinicalTrials.gov registry record
ICG Fluorescence Imaging in Open Fracture Trauma Patients
A clinical trial of Trauma Injury, sponsored by Dartmouth-Hitchcock Medical Center.
- Active
- Registry status
- 180
- Enrollment target
- 4
- Study locations
NCT04416412 is a study of Trauma Injury that is active but no longer recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 180 participants, below the 489-participant average among 15 other Trauma Injury trials with a reported enrollment target (63% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT04416412, a study of Trauma Injury, is active but no longer recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 180 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a prospective observational study that will evaluate the association between bone and tissue perfusion, as measured by indocyanine green (ICG) fluorescence imaging, and complications, in an effort to develop ICG fluorescence imaging as a diagnostic tool to quantitatively guide operative debridement.
Conditions Studied
Interventions
- OTHER Immunofluorescence Imaging
Study Locations (4)
California
- University of California, Irvine - Irvine
Maryland
- University of Maryland, Baltimore R. Cowley Shock Trauma - Baltimore
Massachusetts
- Brigham and Women's Hospital - Boston
New Hampshire
- Dartmouth Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2026-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04416412
The ClinicalTrials.gov registry entry for NCT04416412 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 489-participant average among 15 other Trauma Injury trials with a reported enrollment target (63% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Trauma Injury appearing as the primary indexed condition, and to 1 intervention - of which Immunofluorescence Imaging is the first listed.
NCT04416412 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Maryland, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04416412 about?
NCT04416412 is a clinical study titled "ICG Fluorescence Imaging in Open Fracture Trauma Patients". This is a prospective observational study that will evaluate the association between bone and tissue perfusion, as measured by indocyanine green (ICG) fluorescence imaging, and complications, in an effort to develop ICG fluorescence imaging as a diagnostic tool to quantitatively guide operative debr...
What is the current status of trial NCT04416412?
This trial is currently active not recruiting. The enrollment target is 180 participants. The study started on 2020-10-01. Estimated completion is 2026-01-31.
What conditions does trial NCT04416412 study?
This clinical trial studies the following conditions: Trauma Injury.
What interventions are being tested in trial NCT04416412?
The interventions under investigation include: Immunofluorescence Imaging (OTHER).
Who is sponsoring clinical trial NCT04416412?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04416412 being conducted?
This trial has 4 study locations across California, Maryland, Massachusetts, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pathological Myeloid Activation After Sepsis and Trauma
RECRUITING
-
Therapy Dog Visits for Patients Hospitalized With Traumatic Injuries
RECRUITING · NA
-
Antibiotic Use in Facial Fracture Post Injury
RECRUITING
-
Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury
RECRUITING · NA
-
The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
RECRUITING
-
Bioimpedance for Ortho Trauma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.